Copper and Liver Disease

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 1991 Jan 1

PMID 2044580

Citations 4

Authors

D M Danks

Affiliations

Soon will be listed here.

Abstract

There has been some limited progress in the understanding of the basic defect in Wilson disease and the gene concerned has been located to the chromosome region 13q14. Treatment with zinc has emerged as a definite alternative to penicillamine administration and some shortcomings and/or hazards of both forms of therapy have emerged as their modes of action have been studied more carefully. Tetrathimolybdate may have a place in treatment, especially when rapid complexing of copper is important. Hepatic copper accumulation occurs in a number of cholestatic diseases and they play an important part in pathogenesis and can occasionally lead to neurologic toxic effects. Copper overload in the newborn period when biliary excretion of copper is inefficient may establish a vicious cycle of copper accumulation and liver damage in Indian childhood cirrhosis and less frequently in babies in other countries.

Citing Articles

WILSON'S DISEASE (A report of two cases).

Kanitkar M, Joshi S, Roy N Med J Armed Forces India. 2017; 50(1):63-65.

PMID: 28769165 PMC: 5529699. DOI: 10.1016/S0377-1237(17)31042-0.

Copper associated childhood cirrhosis.

Horslen S, Tanner M, Lyon T, Fell G, Lowry M Gut. 1994; 35(10):1497-500.

PMID: 7959213 PMC: 1375034. DOI: 10.1136/gut.35.10.1497.

Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.

Marcus A, Ammermann C, Klein M, Schmidt M Eur Child Adolesc Psychiatry. 1995; 4(1):46-54.

PMID: 7788483 DOI: 10.1007/BF01987966.

Hepatic disorders. Features and appropriate management.

Aldersley M, OGrady J Drugs. 1995; 49(1):83-102.

PMID: 7705218 DOI: 10.2165/00003495-199549010-00007.

References

Maggiore G, De Giacomo C, Sessa F, Burgio G . Idiopathic hepatic copper toxicosis in a child. J Pediatr Gastroenterol Nutr. 1987; 6(6):980-3. DOI: 10.1097/00005176-198711000-00028. View

Danks D, Campbell P, Smith A, Rogers J . Prognosis of babies with neonatal hepatitis. Arch Dis Child. 1977; 52(5):368-72. PMC: 1544564. DOI: 10.1136/adc.52.5.368. View

Walshe J . Wilson's disease patients can be decoppered. Lancet. 1989; 2(8656):228. DOI: 10.1016/s0140-6736(89)90419-4. View

Tavassoli M, Kishimoto T, Kataoka M . Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J Cell Biol. 1986; 102(4):1298-303. PMC: 2114172. DOI: 10.1083/jcb.102.4.1298. View

Nazer H, Ede R, Mowat A, Williams R . Wilson's disease: clinical presentation and use of prognostic index. Gut. 1986; 27(11):1377-81. PMC: 1434058. DOI: 10.1136/gut.27.11.1377. View

Farrer L, Bonne-Tamir B, Frydman M, Magazanik A, Kidd K, Bowcock A . Predicting genotypes at loci for autosomal recessive disorders using linked genetic markers: application to Wilson's disease. Hum Genet. 1988; 79(2):109-17. DOI: 10.1007/BF00280547. View

Percival S, HARRIS E . Ascorbate enhances copper transport from ceruloplasmin into human K562 cells. J Nutr. 1989; 119(5):779-84. DOI: 10.1093/jn/119.5.779. View

Aagenaes O . Hereditary recurrent cholestasis with lymphoedema--two new families. Acta Paediatr Scand. 1974; 63(3):465-71. DOI: 10.1111/j.1651-2227.1974.tb04832.x. View

Mason J, McQuaid A, Pheiffer H . Can Wilson's disease patients be decoppered?. Lancet. 1989; 1(8652):1455. DOI: 10.1016/s0140-6736(89)90165-7. View

10.

Iyengar V, Brewer G, DICK R, Chung O . Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease. J Lab Clin Med. 1988; 111(3):267-74. View

11.

Walshe J, Dixon A . Dangers of non-compliance in Wilson's disease. Lancet. 1986; 1(8485):845-7. DOI: 10.1016/s0140-6736(86)90949-9. View

12.

Danks D, Metz G, Sewell R, Prewett E . Wilson's disease in adults with cirrhosis but no neurological abnormalities. BMJ. 1990; 301(6747):331-2. PMC: 1663627. DOI: 10.1136/bmj.301.6747.331. View

13.

Danks D . Copper-induced dystonia secondary to cholestatic liver disease. Lancet. 1990; 335(8686):410. DOI: 10.1016/0140-6736(90)90240-6. View

14.

Scheinberg I, Sternlieb I, Schilsky M, Stockert R . Penicillamine may detoxify copper in Wilson's disease. Lancet. 1987; 2(8550):95. DOI: 10.1016/s0140-6736(87)92753-x. View

15.

Harper P, Walshe J . Reversible pancytopenia secondary to treatment with tetrathiomolybdate. Br J Haematol. 1986; 64(4):851-3. DOI: 10.1111/j.1365-2141.1986.tb02250.x. View

16.

Henriksen N, Drablos P, Aagenaes O . Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis. Arch Dis Child. 1981; 56(8):622-7. PMC: 1627279. DOI: 10.1136/adc.56.8.622. View

17.

Dameron C, HARRIS E . Regulation of aortic CuZn-superoxide dismutase with copper. Caeruloplasmin and albumin re-activate and transfer copper to the enzyme in culture. Biochem J. 1987; 248(3):669-75. PMC: 1148601. DOI: 10.1042/bj2480669. View

18.

Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues J . Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr. 1987; 110(2):195-200. DOI: 10.1016/s0022-3476(87)80153-1. View

19.

Brewer G, Terry C, Aisen A, Hill G . Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 1987; 44(5):490-3. DOI: 10.1001/archneur.1987.00520170020016. View

20.

Smith A, Danks D . Secondary copper accumulation with neurological damage in child with chronic liver disease. Br Med J. 1978; 2(6149):1400-1. PMC: 1608630. DOI: 10.1136/bmj.2.6149.1400-a. View